Sandoz To Acquire Aspen’s Japanese Operations

Up to €400m Deal Strengthens Hospitals Portfolio

 
• By Aidan Fry

Sandoz is to pay up to €400m for Aspen’s anesthetics and other specialty off-patent brands in Japan, strengthening the Novartis division’s local position in the hospitals market.

Spray_Bottle_Xylocaine
The lidocaine-based Xylocaine anesthetic is one of the key hospital assets that Sandoz is set to pick up through its purchase of Aspen’s Japanese operations • Source: Shutterstock

More from Deals

More from Business